CCEL
Price:
$7.26
Market Cap:
$58.53M
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company marke...[Read more]
Industry
Medical - Care Facilities
IPO Date
1994-04-04
Stock Exchange
NASDAQ
Ticker
CCEL
According to Cryo-Cell International, Inc.’s latest financial reports and current stock price. The company's current ROE is 85.69%. This represents a change of 334.12% compared to the average of 19.74% of the last 4 quarters.
The mean historical ROE of Cryo-Cell International, Inc. over the last ten years is -38.35%. The current 85.69% ROE has changed -323.46% with respect to the historical average. Over the past ten years (40 quarters), CCEL's ROE was at its highest in in the November 2023 quarter at 101.44%. The ROE was at its lowest in in the August 2023 quarter at -4210.61%.
Average
-38.35%
Median
-11.84%
Minimum
-181.81%
Maximum
86.32%
Discovering the peaks and valleys of Cryo-Cell International, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.06%
Maximum Annual ROE = 86.32%
Minimum Annual Increase = -465.14%
Minimum Annual ROE = -181.81%
Year | ROE | Change |
---|---|---|
2023 | 86.32% | -147.47% |
2022 | -181.81% | -465.14% |
2021 | 49.79% | -136.61% |
2020 | -136.00% | 312.78% |
2019 | -32.95% | -443.35% |
2018 | 9.60% | -151.82% |
2017 | -18.52% | -316.09% |
2016 | 8.57% | -105.25% |
2015 | -163.30% | 3.06% |
2014 | -5.16% | 1.64% |
The current ROE of Cryo-Cell International, Inc. (CCEL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-15.24%
5-year avg
-42.93%
10-year avg
-38.35%
Cryo-Cell International, Inc.’s ROE is less than National HealthCare Corporation (10.02%), greater than InnovAge Holding Corp. (-7.60%), less than The Pennant Group, Inc. (13.39%), less than Encompass Health Corporation (21.39%), greater than Aesthetic Medical International Holdings Group Limited (-75.32%), greater than AirSculpt Technologies, Inc. (-4.06%), less than Aveanna Healthcare Holdings Inc. (102.70%), greater than The Oncology Institute, Inc. (-123.75%), greater than Brookdale Senior Living Inc. (-51.50%), greater than Surgery Partners, Inc. (0.35%), less than Select Medical Holdings Corporation (18.46%), less than The Ensign Group, Inc. (14.83%), greater than Pediatrix Medical Group, Inc. (-32.29%), greater than P3 Health Partners Inc. (-43.19%), less than Sonida Senior Living, Inc. (43.78%), less than Acadia Healthcare Company, Inc. (9.65%), less than DocGo Inc. (9.91%), less than Concord Medical Services Holdings Limited (12.96%),
Company | ROE | Market cap |
---|---|---|
10.02% | $1.80B | |
-7.60% | $799.43M | |
13.39% | $1.09B | |
21.39% | $10.06B | |
-75.32% | $15.93M | |
-4.06% | $383.85M | |
102.70% | $868.55M | |
-123.75% | $21.14M | |
-51.50% | $1.24B | |
0.35% | $3.70B | |
18.46% | $4.71B | |
14.83% | $8.78B | |
-32.29% | $1.30B | |
-43.19% | $125.63M | |
43.78% | $481.24M | |
9.65% | $3.92B | |
9.91% | $347.88M | |
12.96% | $32.69M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cryo-Cell International, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cryo-Cell International, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Cryo-Cell International, Inc.'s ROE?
How is the ROE calculated for Cryo-Cell International, Inc. (CCEL)?
What is the highest ROE for Cryo-Cell International, Inc. (CCEL)?
What is the 3-year average ROE for Cryo-Cell International, Inc. (CCEL)?
What is the 5-year average ROE for Cryo-Cell International, Inc. (CCEL)?
How does the current ROE for Cryo-Cell International, Inc. (CCEL) compare to its historical average?